Marianne de Backer - 22 Jun 2022 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
29 Jun 2022, 16:14:06 UTC
Previous filing
07 Jan 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Award $0 +11,333 +412% $0.000000 14,083 22 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Stock Option (Right to Buy) Award $0 +17,000 $0.000000 17,000 22 Jun 2022 Common Stock 17,000 $3.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.